Annual Net Income
-$46.05 M
-$19.28 M-72.00%
December 31, 2023
Summary
- As of February 7, 2025, ZVRA annual net profit is -$46.05 million, with the most recent change of -$19.28 million (-72.00%) on December 31, 2023.
- During the last 3 years, ZVRA annual net income has fallen by -$33.29 million (-260.89%).
- ZVRA annual net income is now -781.15% below its all-time high of -$5.23 million, reached on December 1, 2013.
Performance
ZVRA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$33.23 M
-$13.30 M-66.75%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA quarterly net profit is -$33.23 million, with the most recent change of -$13.30 million (-66.75%) on September 30, 2024.
- Over the past year, ZVRA quarterly net income has dropped by -$13.33 million (-67.03%).
- ZVRA quarterly net income is now -440.14% below its all-time high of $9.77 million, reached on June 1, 2016.
Performance
ZVRA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$89.66 M
-$22.86 M-34.22%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA TTM net profit is -$89.66 million, with the most recent change of -$22.86 million (-34.22%) on September 30, 2024.
- Over the past year, ZVRA TTM net income has dropped by -$43.62 million (-94.71%).
- ZVRA TTM net income is now -72797.56% below its all-time high of -$123.00 thousand, reached on March 1, 2022.
Performance
ZVRA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ZVRA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.0% | -67.0% | -94.7% |
| 3 y3 years | -260.9% | -67.0% | -94.7% |
| 5 y5 years | +18.4% | -67.0% | -94.7% |
ZVRA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -438.3% | at low | -677.8% | at low | <-9999.0% | at low |
| 5 y | 5-year | -438.3% | at low | -635.6% | at low | <-9999.0% | at low |
| alltime | all time | -781.1% | +18.4% | -440.1% | at low | <-9999.0% | at low |
Zevra Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.23 M(+66.8%) | -$89.66 M(+34.2%) |
| Jun 2024 | - | -$19.93 M(+19.9%) | -$66.81 M(+35.1%) |
| Mar 2024 | - | -$16.62 M(-16.4%) | -$49.45 M(+7.4%) |
| Dec 2023 | -$46.05 M(+72.0%) | -$19.89 M(+91.9%) | -$46.05 M(+125.7%) |
| Sep 2023 | - | -$10.37 M(+302.9%) | -$20.41 M(+22.5%) |
| Jun 2023 | - | -$2.57 M(-80.5%) | -$16.66 M(-56.3%) |
| Mar 2023 | - | -$13.22 M(-329.9%) | -$38.13 M(+42.4%) |
| Dec 2022 | -$26.77 M(+212.9%) | $5.75 M(-186.9%) | -$26.77 M(-24.0%) |
| Sep 2022 | - | -$6.62 M(-72.5%) | -$35.23 M(+16.0%) |
| Jun 2022 | - | -$24.04 M(+1189.8%) | -$30.37 M(>+9900.0%) |
| Mar 2022 | - | -$1.86 M(-31.0%) | -$123.00 K(-98.6%) |
| Dec 2021 | -$8.55 M(-33.0%) | - | - |
| Dec 2021 | - | -$2.70 M(+53.7%) | -$8.55 M(-20.1%) |
| Sep 2021 | - | -$1.76 M(-128.4%) | -$10.71 M(-10.5%) |
| Jun 2021 | - | $6.20 M(-160.2%) | -$11.96 M(-30.9%) |
| Mar 2021 | - | -$10.30 M(+112.0%) | -$17.30 M(+35.6%) |
| Dec 2020 | -$12.76 M(-48.0%) | -$4.86 M(+61.4%) | -$12.76 M(-8.5%) |
| Sep 2020 | - | -$3.01 M(-450.3%) | -$13.94 M(+77.2%) |
| Jun 2020 | - | $859.00 K(-114.9%) | -$7.87 M(-56.2%) |
| Mar 2020 | - | -$5.75 M(-4.7%) | -$17.98 M(-26.7%) |
| Dec 2019 | -$24.52 M | -$6.04 M(-297.1%) | -$24.52 M(+3.6%) |
| Sep 2019 | - | $3.06 M(-133.1%) | -$23.67 M(-43.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$9.26 M(-24.7%) | -$41.80 M(-1.7%) |
| Mar 2019 | - | -$12.29 M(+137.1%) | -$42.54 M(-24.7%) |
| Dec 2018 | -$56.47 M(+30.1%) | -$5.18 M(-65.6%) | -$56.47 M(-8.7%) |
| Sep 2018 | - | -$15.07 M(+50.8%) | -$61.85 M(+9.0%) |
| Jun 2018 | - | -$9.99 M(-61.9%) | -$56.76 M(+6.5%) |
| Mar 2018 | - | -$26.22 M(+148.1%) | -$53.28 M(+22.8%) |
| Dec 2017 | -$43.39 M(+162.7%) | -$10.57 M(+5.9%) | -$43.39 M(+1.5%) |
| Sep 2017 | - | -$9.98 M(+53.2%) | -$42.76 M(-7.4%) |
| Jun 2017 | - | -$6.52 M(-60.1%) | -$46.19 M(+54.5%) |
| Mar 2017 | - | -$16.32 M(+64.3%) | -$29.90 M(+81.1%) |
| Dec 2016 | -$16.52 M(-69.8%) | -$9.94 M(-25.9%) | -$16.52 M(+4.6%) |
| Sep 2016 | - | -$13.41 M(-237.3%) | -$15.78 M(+30.3%) |
| Jun 2016 | - | $9.77 M(-432.9%) | -$12.11 M(-76.5%) |
| Mar 2016 | - | -$2.93 M(-68.1%) | -$51.62 M(-5.6%) |
| Dec 2015 | -$54.66 M(+123.5%) | -$9.20 M(-5.6%) | -$54.66 M(-4.6%) |
| Sep 2015 | - | -$9.74 M(-67.2%) | -$57.30 M(+4.8%) |
| Jun 2015 | - | -$29.74 M(+397.9%) | -$54.69 M(+91.8%) |
| Mar 2015 | - | -$5.97 M(-49.5%) | -$28.52 M(+16.6%) |
| Dec 2014 | -$24.45 M(+367.9%) | -$11.84 M(+65.9%) | -$24.45 M(+93.9%) |
| Sep 2014 | - | -$7.14 M(+99.8%) | -$12.61 M(+130.3%) |
| Jun 2014 | - | -$3.57 M(+87.5%) | -$5.48 M(+187.5%) |
| Mar 2014 | - | -$1.91 M | -$1.91 M |
| Dec 2013 | -$5.23 M | - | - |
FAQ
- What is Zevra Therapeutics annual net profit?
- What is the all time high annual net income for Zevra Therapeutics?
- What is Zevra Therapeutics annual net income year-on-year change?
- What is Zevra Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly net income year-on-year change?
- What is Zevra Therapeutics TTM net profit?
- What is the all time high TTM net income for Zevra Therapeutics?
- What is Zevra Therapeutics TTM net income year-on-year change?
What is Zevra Therapeutics annual net profit?
The current annual net income of ZVRA is -$46.05 M
What is the all time high annual net income for Zevra Therapeutics?
Zevra Therapeutics all-time high annual net profit is -$5.23 M
What is Zevra Therapeutics annual net income year-on-year change?
Over the past year, ZVRA annual net profit has changed by -$19.28 M (-72.00%)
What is Zevra Therapeutics quarterly net profit?
The current quarterly net income of ZVRA is -$33.23 M
What is the all time high quarterly net income for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly net profit is $9.77 M
What is Zevra Therapeutics quarterly net income year-on-year change?
Over the past year, ZVRA quarterly net profit has changed by -$13.33 M (-67.03%)
What is Zevra Therapeutics TTM net profit?
The current TTM net income of ZVRA is -$89.66 M
What is the all time high TTM net income for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM net profit is -$123.00 K
What is Zevra Therapeutics TTM net income year-on-year change?
Over the past year, ZVRA TTM net profit has changed by -$43.62 M (-94.71%)